(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 8.37% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.07%.
Albemarle's revenue in 2026 is $5,142,733,000.On average, 27 Wall Street analysts forecast ALB's revenue for 2026 to be $661,476,445,860, with the lowest ALB revenue forecast at $525,009,365,100, and the highest ALB revenue forecast at $864,762,900,360. On average, 24 Wall Street analysts forecast ALB's revenue for 2027 to be $721,107,139,180, with the lowest ALB revenue forecast at $587,468,391,700, and the highest ALB revenue forecast at $1,061,449,910,540.
In 2028, ALB is forecast to generate $768,010,332,740 in revenue, with the lowest revenue forecast at $603,613,460,840 and the highest revenue forecast at $983,906,439,780.